Literature DB >> 28666299

Incidence of Bacteriuria after Urodynamic Study with or without Antibiotic Prophylaxis in Women with Urinary Incontinence.

Elizabeth Yukie Hirakauva1, Ana Maria Homem de Mello Bianchi-Ferraro1, Eliana Viana Monteiro Zucchi1, Marcio Massashi Kajikawa1, Manoel João Batista Castello Girão1, Marair Gracio Ferreira Sartori1, Zsuzsanna Ilona Katalin de Jarmy-Di Bella1.   

Abstract

Introduction The presence of bacteria in urine is called bacteriuria, which may be symptomatic or asymptomatic. The manipulation of the urinary tract during urodynamic study (UDS), which is an invasive procedure, can result in urinary tract infection (UTI). Studies on the use of prophylactic antibiotics for UDSs are contradictory. Some investigators concluded that they were valuable and others did not. The objective of this study is to evaluate the efficacy of antibiotic prophylaxis before UDS. This is a placebo-control randomized double-blind study. Methods Two-hundred and seventeen women affected by urinary incontinence were eligible for this study. All patients had presented negative urine culture previous to the UDS. They were randomized in four groups: group A received placebo, group B received 500 mg of levofloxacin, group C received 80 mg trimethoprim and 400 mg sulfamethoxazole and group D received 100 mg of nitrofurantoin. A urine culture was performed 14 days after the UDS. Results We observed asymptomatic bacteriuria after the UDS in five patients in group A, one in group B, one in group C and one in group D. Only one patient on group A had symptomatic bacteriuria. We didn't observe statistical difference between the groups. When we recategorized the patients in two groups, the incidence of bacteriuria was significantly higher in the placebo group compared with the antibiotic group. Conclusion The conclusion is that antibiotic prophylaxis before the UDS did not reduce the incidence of UTI in women within the target population. Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.

Entities:  

Mesh:

Year:  2017        PMID: 28666299     DOI: 10.1055/s-0037-1604066

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  6 in total

1.  Dipstick urinalysis does not predict post-urodynamic study morbidity.

Authors:  Kasey Roberts; Anood Alfahmy; Diana Mitchell; Stacy Kamumbu; Audry Sebikali-Potts; David Sheyn
Journal:  Int Urogynecol J       Date:  2022-06-28       Impact factor: 2.894

2.  Prophylactic Antibiotics for Urinary Tract Infections after Urodynamic Studies: A Meta-Analysis.

Authors:  Xiao-Yu Wu; Yu Cheng; Sheng-Fei Xu; Qing Ling; Xiao-Yi Yuan; Guang-Hui Du
Journal:  Biomed Res Int       Date:  2021-02-28       Impact factor: 3.411

3.  Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?

Authors:  Pawel Miotla; Sara Wawrysiuk; Kurt Naber; Ewa Markut-Miotla; Pawel Skorupski; Katarzyna Skorupska; Tomasz Rechberger
Journal:  Biomed Res Int       Date:  2018-11-05       Impact factor: 3.411

Review 4.  Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; María Yanira Ortega-González; David Manuel Castro-Díaz
Journal:  Curr Bladder Dysfunct Rep       Date:  2021-12-01

5.  The impact of the coronavirus disease 2019 pandemic on changes in antimicrobial prophylaxis and development of genito-urinary tract infections after urodynamic study: A retrospective comparative study of a single rehabilitation hospital in Japan.

Authors:  Shigeto Mukai; Masashi Nomi; Sae Kozawa; Akihiro Yanagiuchi; Katsumi Shigemura; Atsushi Sengoku
Journal:  Neurourol Urodyn       Date:  2022-06-08       Impact factor: 2.367

Review 6.  Antibiotic prophylaxis for urodynamic testing in women: a systematic review.

Authors:  Anouk Benseler; Breffini Anglim; Zi Ying Zhao; Chris Walsh; Colleen D McDermott
Journal:  Int Urogynecol J       Date:  2020-08-26       Impact factor: 2.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.